Jung Cassie 4
4 · Aquestive Therapeutics, Inc. · Filed Oct 17, 2025
Insider Transaction Report
Form 4
Jung Cassie
Chief Operating Officer
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-15−25,000→ 0 totalExercise: $3.10Exp: 2031-06-10→ Common Stock (25,000 underlying) - Sale
Common Stock
2025-10-15$7.01/sh−67,575$473,701→ 240,771 total - Exercise/Conversion
Common Stock
2025-10-15$3.10/sh+25,000$77,568→ 308,346 total
Holdings
- 2,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.
- [F3]This option was granted on June 10, 2021 and is fully vested.